Ropinirole CR - A novel extended-release formulation - Demonstrates onset of symptom improvement from the first night of treatment in patients with moderate-to-severe primary restless legs syndrome

被引：0

作者：

Becker, P.

Bogan, R.

Earl, N.

机构：

[1] Univ Texas, SW Med Ctr, Dallas, TX USA

[2] SleepMed S Carolina, Columbia, SC USA

[3] GlaxoSmithKline Inc, Res Triangle Pk, NC USA

来源：

SLEEP | 2007年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

823

引用

页码：A282 / A283

页数：2

共 19 条

[1] Ropinirole CR extended release demonstrates improvements from the first night of treatment in patients with moderate-to-severe primary restless legs syndrome (RLS)
Ferguson, James M.
Bogan, Richard
Earl, Nancy
NEUROLOGY, 2007, 68 (12) : A256 - A256
[2] Ropinirole CR - A novel extended-release formulation - Reduces overall severity of illness in patients with moderate-to-severe primary restless legs syndrome
Schmidt, M.
Ferguson, J.
Earl, N.
SLEEP, 2007, 30 : A290 - A290
[3] A novel extended-release formulation ropinirole CR - Improves quality of life in patients with moderate-to-severe primary restless legs syndrome: Results from a 12-week pivotal trial
Schmidt, M.
Ziman, R.
Calloway, M.
SLEEP, 2007, 30 : A289 - A289
[4] Ropinirole CR - An extended-release formulation - Improves quality of life in patients with moderate-to-severe primary restless legs syndrome (RLS): Results from a 12-week pivotal study
Ziman, Ronald
Bogan, Richard
Calloway, Michael O.
NEUROLOGY, 2007, 68 (12) : A256 - A256
[5] Patient satisfaction with ropinirole CR, a once-daily extended-release treatment for moderate-to-severe primary restless legs syndrome results from a 12-week pivotal study
Becker, P.
Castiglia, M.
SLEEP, 2007, 30 : A285 - A285
[6] Ropinirolle CR - A new extended-release formulation - Reduces symptom severity in patients with primary restless legs syndrome (RLS)
Ferguson, James M.
Becker, Philip
Williams, Nicola J.
NEUROLOGY, 2007, 68 (12) : A255 - A256
[7] Tolerability with maintained efficacy after overnight switch from immediate release (IR) ropinirole to a novel extended-release formulation - Ropinirole CR - In restless legs syndrome
Lee, D.
Hosford, D.
SLEEP, 2007, 30 : A289 - A289
[8] Ropinirole relieves mood symptoms in patients with moderate-to-severe primary restless legs syndrome (RLS)
Thomas, KM
Becker, P
Watson, CB
NEUROLOGY, 2006, 66 (05) : A81 - A81
[9] Tolerability with no loss of efficacy after overnight conversion from immediate-release ropinirole to an extended-release formulation - ropinirole CR - in restless legs syndrome
Isaacson, S.
Castiglia, M.
Hodge, R.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S74 - S75
[10] Ropinirole CR improves the symptoms of restless legs syndrome from the first night of treatment
Bogan, R.
Castiglia, M.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S74 - S74

← 1 2 →